RESUMO
No uniformly beneficial treatments exist for dogs with non-lymphomatous nasal tumours (NLNT) that relapse after radiotherapy (RT). Reirradiation may prolong survival and improve quality of life. In this retrospective study, we describe outcomes for 11 dogs that had CT-confirmed locoregional progression of NLNT after an initial course of stereotactic RT (SRT#1; 10 Gy × 3) and were then re-treated with the same type of protocol (SRT#2, also 10 Gy × 3). The median time between SRT #1 and SRT #2 was 243 days (95% CI: 78-385 days). Ten dogs (91%) had a clinical benefit after SRT#1; five dogs (45%) had clinical benefit after SRT#2. Adverse events after SRT#2 included nasocutaneous or oronasal fistula formation (N = 3 at 180, 270, and 468 days), seizures (N = 2 at 78 and 330 days), bacterial or fungal rhinitis (N = 2 at 240 and 385 days), and facial swelling (N = 1 at 90 days). All 11 dogs have died, due to disease progression, presumed radiotoxicity, or declining quality of life; in most cases, it was difficult to discern between these conditions. The median overall survival time (OST) from SRT#1 was 745 days (95% CI: 360-1132). The median overall survival time (OST) from SRT #2 was 448 days (95% CI: 112-626). For these dogs, survival was prolonged, but adverse events after SRT#2 were common (8/11; 73%). Therefore, before consenting to re-irradiation with this protocol, pet owners should be counselled about survivorship challenges, including risk for severe toxicities, and persistence of clinical signs.
Assuntos
Doenças do Cão , Neoplasias Nasais , Radiocirurgia , Reirradiação , Animais , Doenças do Cão/radioterapia , Cães , Recidiva Local de Neoplasia/cirurgia , Recidiva Local de Neoplasia/veterinária , Neoplasias Nasais/radioterapia , Neoplasias Nasais/veterinária , Qualidade de Vida , Radiocirurgia/efeitos adversos , Radiocirurgia/métodos , Radiocirurgia/veterinária , Reirradiação/veterinária , Estudos Retrospectivos , Resultado do TratamentoRESUMO
ABSTRACT: Prostate-specific membrane antigen (PSMA) is universally expressed in the endothelial cells of tumor-associated neovasculature of juvenile nasopharyngeal angiofibroma. Functional 68Ga-PSMA PET/CT also enables easier differentiation of the residual tumor from postoperative changes. An 18-year-old man with the residual intracranial disease received radiotherapy after surgery. In PSMA PET/CT imaging, uptake was noted initially only in the residual disease, and the same was absent after successful response to radiotherapy, unlike contrast MRI, which showed persistent enhancement. Functional 68Ga-PSMA PET/CT may be a very useful tool clinically for identifying early responses to radiotherapy compared with conventional structural imaging.
Assuntos
Angiofibroma/diagnóstico por imagem , Angiofibroma/radioterapia , Glicoproteínas de Membrana , Neoplasias Nasais/diagnóstico por imagem , Neoplasias Nasais/radioterapia , Compostos Organometálicos , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Adolescente , Isótopos de Gálio , Radioisótopos de Gálio , Humanos , Imageamento por Ressonância Magnética , Masculino , Resultado do TratamentoRESUMO
BACKGROUND: Cost-effectiveness is a pivotal consideration for clinical decision making of high-tech cancer treatment in developing countries. Intensity-modulated proton radiation therapy (IMPT, the advanced form of proton beam therapy) has been found to improve the prognosis of the patients with paranasal sinus and nasal cavity cancers compared with intensity-modulated photon-radiation therapy (IMRT). However, the cost-effectiveness of IMPT has not yet been fully evaluated. This study aimed at evaluating the cost-effectiveness of IMPT versus IMRT for treatment decision making of paranasal sinus and nasal cavity cancers in Chinese settings. METHODS: A 3-state Markov model was designed for cost-effectiveness analysis. A base case evaluation was performed on a patient of 47-year-old (median age of patients with paranasal sinus and nasal cavity cancers in China). Model robustness was examined by probabilistic sensitivity analysis, Markov cohort analysis and Tornado diagram. Cost-effective scenarios of IMPT were further identified by one-way sensitivity analyses and stratified analyses were performed for different age levels. The outcome measure of the model was the incremental cost-effectiveness ratio (ICER). A strategy was defined as cost-effective if the ICER was below the societal willingness-to-pay (WTP) threshold of China (30,828 US dollars ($) / quality-adjusted life year (QALY)). RESULTS: IMPT was identified as being cost-effective for the base case at the WTP of China, providing an extra 1.65 QALYs at an additional cost of $38,928.7 compared with IMRT, and had an ICER of $23,611.2 / QALY. Of note, cost-effective scenarios of IMPT only existed in the following independent conditions: probability of IMPT eradicating cancer ≥0.867; probability of IMRT eradicating cancer ≤0.764; or cost of IMPT ≤ $52,163.9. Stratified analyses for different age levels demonstrated that IMPT was more cost-effective in younger patients than older patients, and was cost-effective only in patients ≤56-year-old. CONCLUSIONS: Despite initially regarded as bearing high treatment cost, IMPT could still be cost-effective for patients with paranasal sinus and nasal cavity cancers in China. The tumor control superiority of IMPT over IMRT and the patient's age should be the principal considerations for clinical decision of prescribing this new irradiation technique.
Assuntos
Análise Custo-Benefício , Cavidade Nasal/patologia , Neoplasias Nasais/radioterapia , Neoplasias dos Seios Paranasais/radioterapia , Fótons/uso terapêutico , Terapia com Prótons/economia , Radioterapia de Intensidade Modulada/economia , Fatores Etários , Idoso , China/epidemiologia , Tomada de Decisão Clínica , Intervalo Livre de Doença , Custos de Cuidados de Saúde , Humanos , Expectativa de Vida , Cadeias de Markov , Pessoa de Meia-Idade , Modelos Econômicos , Método de Monte Carlo , Neoplasias Nasais/economia , Neoplasias Nasais/mortalidade , Neoplasias Nasais/patologia , Neoplasias dos Seios Paranasais/economia , Neoplasias dos Seios Paranasais/mortalidade , Neoplasias dos Seios Paranasais/patologia , Seios Paranasais/patologia , Prognóstico , Terapia com Prótons/métodos , Anos de Vida Ajustados por Qualidade de Vida , Radioterapia de Intensidade Modulada/métodos , Taxa de Sobrevida , Resultado do TratamentoRESUMO
PURPOSE: The purpose of this study was to develop a patient-specific elastic skin applicator and to evaluate its dosimetric characteristics for high-dose-rate (HDR) brachytherapy. METHODS AND MATERIALS: We simulated the treatment of a nonmelanoma skin cancer on the nose. An elastic skin applicator was manufactured by pouring the Dragon Skin (Smooth-On Inc., Easton, PA) with a shore hardness of 10A into an applicator mold. The rigid skin applicator was printed using high-impact polystyrene with a shore hardness of 73D. HDR plans were generated using a Freiburg Flap (FF) applicator and patient-specific rigid and elastic applicators. For dosimetric assessment, dose-volumetric parameters for target volume and normal organs were evaluated. Global gamma evaluations were performed, comparing film measurements and treatment planning system calculations with various gamma criteria. The 10% low-dose threshold was applied. RESULTS: The V120% values of the target volume were 56.9%, 70.3%, and 70.2% for HDR plans using FF, rigid, and elastic applicators, respectively. The maximum doses of the right eyeball were 21.7 Gy, 20.5 Gy, and 20.5 Gy for the HDR plans using FF, rigid, and elastic applicators, respectively. The average gamma passing rates were 82.5% ± 1.5%, 91.6% ± 0.8%, and 94.8% ± 0.2% for FF, rigid, and elastic applicators, respectively, with 3%/3 mm criterion. CONCLUSIONS: Patient-specific elastic skin applicator showed better adhesion to irregular or curved body surfaces, resulting in better agreement between planned and delivered dose distributions. The applicator suggested in this study can be effectively implemented clinically.
Assuntos
Braquiterapia/instrumentação , Carcinoma Basocelular/radioterapia , Carcinoma de Células Escamosas/radioterapia , Neoplasias Nasais/radioterapia , Neoplasias Cutâneas/radioterapia , Braquiterapia/métodos , Olho , Feminino , Humanos , Impressão Tridimensional , Doses de Radiação , Radiometria , Dosagem Radioterapêutica , Planejamento da Radioterapia Assistida por Computador/métodosRESUMO
The number of patients treated by proton beam therapy in Japan since 2000 has increased; in 2016, 11 proton facilities were available to treat patients. Notably, proton beam therapy is very useful for pediatric cancer; since the pediatric radiation dose to normal tissues should be reduced as much as possible because of the effect of radiation on growth, intellectual development, endocrine organ function and secondary cancer development. Hepatocellular carcinoma is common in Asia, and most of the studies of proton beam therapy for liver cancer have been reported by Japanese investigators. Proton beam therapy is also a standard treatment for nasal and paranasal lesions and lesions at the base of the skull, because the radiation dose to critical organs such as the eyes, optic nerves and central nervous system can be reduced with proton beam therapy. For prostate cancer, comparative studies that address adverse effects, safety, patient quality of life and socioeconomic issues should be performed to determine the appropriate use of proton beam therapy for prostate cancer. Regarding new proton beam therapy applications, experience with proton beam therapy combined with chemotherapy is limited, although favorable outcomes have been recently reported for locally advanced lung cancer, esophageal cancer and pancreatic cancer. Therefore, 'chemoproton' therapy appears to be a very attractive field for further clinical investigations. In conclusion, there are cost issues and considerations regarding national insurance for the use of proton beam therapy in Japan. Further studies and discussions are needed to address the use of proton beam therapy for several types of cancers, and for maintaining the quality of life of patients while retaining a high cure rate.
Assuntos
Neoplasias/radioterapia , Terapia com Prótons/métodos , Institutos de Câncer , Neoplasias Esofágicas/radioterapia , Humanos , Cobertura do Seguro , Japão , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/radioterapia , Masculino , Neoplasias/patologia , Neoplasias Nasais/radioterapia , Neoplasias Pancreáticas/radioterapia , Neoplasias da Próstata/radioterapia , Terapia com Prótons/economia , Terapia com Prótons/instrumentaçãoRESUMO
PURPOSE: To investigate whether interruptions in radiotherapy are associated with decreased survival in a population-based sample of head-and-neck cancer patients. METHODS AND MATERIALS: Using the Surveillance, Epidemiology, and End Results-Medicare linked database we identified Medicare beneficiaries aged 66 years and older diagnosed with local-regional head-and-neck cancer during the period 1997-2003. We examined claims records of 3864 patients completing radiotherapy for the presence of one or more 5-30-day interruption(s) in therapy. We then performed Cox regression analyses to estimate the association between therapy interruptions and survival. RESULTS: Patients with laryngeal tumors who experienced an interruption in radiotherapy had a 68% (95% confidence interval, 41-200%) increased risk of death, compared with patients with no interruptions. Patients with nasal cavity, nasopharynx, oral, salivary gland, and sinus tumors had similar associations between interruptions and increased risk of death, but these did not reach statistical significance because of small sample sizes. CONCLUSIONS: Treatment interruptions seem to influence survival time among patients with laryngeal tumors completing a full course of radiotherapy. At all head-and-neck sites, the association between interruptions and survival is sensitive to confounding by stage and other treatments. Further research is needed to develop methods to identify patients most susceptible to interruption-induced mortality.
Assuntos
Neoplasias de Cabeça e Pescoço/mortalidade , Neoplasias de Cabeça e Pescoço/radioterapia , Suspensão de Tratamento , Idoso , Intervalos de Confiança , Feminino , Humanos , Neoplasias Hipofaríngeas/mortalidade , Neoplasias Hipofaríngeas/radioterapia , Neoplasias Laríngeas/mortalidade , Neoplasias Laríngeas/radioterapia , Masculino , Medicare/estatística & dados numéricos , Neoplasias Nasofaríngeas/mortalidade , Neoplasias Nasofaríngeas/radioterapia , Neoplasias Nasais/mortalidade , Neoplasias Nasais/radioterapia , Neoplasias dos Seios Paranasais/mortalidade , Neoplasias dos Seios Paranasais/radioterapia , Análise de Regressão , Estudos Retrospectivos , Programa de SEER/estatística & dados numéricos , Neoplasias das Glândulas Salivares/mortalidade , Neoplasias das Glândulas Salivares/radioterapia , Tamanho da Amostra , Estados UnidosRESUMO
The purpose of this study was to utilize state-of-the-art on-board digital kilovoltage (kV) imaging to determine the systematic and random set-up errors of an immobilization device designed for canine and feline cranial radiotherapy treatments. The immobilization device is comprised of a custom made support bridge, bite block, vacuum-based foam mold and a modified thermoplastic mask attached to a commercially available head rest designed for human radiotherapy treatments. The immobilization device was indexed to a Varian exact couch-top designed for image guided radiation therapy (IGRT). Daily orthogonal kV images were compared to Eclipse treatment planning digitally reconstructed radiographs (DRRs). The orthogonal kV images and DRRs were directly compared online utilizing the Varian on-board imaging (OBI) system with set-up corrections mmediately and remotely transferred to the treatment couch prior to treatment delivery. Off-line review of 124 patient treatments indicates systematic errors consisting of +0.18 mm vertical, +0.39mm longitudinal and -0.08 mm lateral. The random errors corresponding to 2 standard deviations (95% CI) consist of 4.02 mm vertical, 2.97 mm longitudinal and 2.53 mm lateral and represent conservative CTV to PTV margins if kV OBI is not available. Use of daily kV OBI along with the cranial immobilization device permits reduction of the CTV to PTV margins to approximately 2.0 mm.
Assuntos
Doenças do Gato/radioterapia , Doenças do Cão/radioterapia , Imobilização/veterinária , Neoplasias/veterinária , Radioterapia de Intensidade Modulada/veterinária , Animais , Neoplasias Encefálicas/diagnóstico por imagem , Neoplasias Encefálicas/radioterapia , Neoplasias Encefálicas/veterinária , Doenças do Gato/diagnóstico por imagem , Gatos , Doenças do Cão/diagnóstico por imagem , Cães , Feminino , Imobilização/instrumentação , Imobilização/métodos , Masculino , Movimento , Neoplasias/diagnóstico por imagem , Neoplasias/radioterapia , Neoplasias Nasais/diagnóstico por imagem , Neoplasias Nasais/radioterapia , Neoplasias Nasais/veterinária , Sistemas On-Line , Neoplasias Hipofisárias/diagnóstico por imagem , Neoplasias Hipofisárias/radioterapia , Neoplasias Hipofisárias/veterinária , Radiografia , Dosagem Radioterapêutica , Radioterapia de Intensidade Modulada/instrumentação , Radioterapia de Intensidade Modulada/métodos , Resultado do TratamentoRESUMO
BACKGROUND: Adenocarcinomas of the nasal cavity and the paranasal sinuses after occupational exposure to sawdust from oak and beech have been listed as occupational diseases in Germany since 1988. Given that modes of treatment have changed, we analyzed the guidelines based on the recommendations of Hartung et al. for developing an expert assessment on reduced earning capacity. MATERIALS AND METHODS: A retrospective analysis of 43 cases which had been evaluated between March 1994 and February 2007 for an occupational disease #4203, in the Ear-Nose-Throat clinic of the Münster University Hospital, Germany. RESULTS: Following the guidelines of Hartung et al., it was impossible to formally classify 21 of 43 cases (48.8 %) in an unambiguous manner. This was primarily due to the assessment of the results of radiotherapy, either adjuvant or therapeutic, as well as the grading of postoperative dysfunction in the area of the sinuses operated on (Rhinitis, Ozaena). Suggestions for a revision of the classification system include a modified assessment of radiotherapy as well as evidence for grading post-therapeutic inflammations of the sinus operated on based on the need for further care. These changes enable all cases in question to be classified unambiguously. CONCLUSIONS: The use of the revised guidelines is recommended for expert assessment of adenocarcinomas of the nasal cavity and the paranasal sinuses caused by wood dust.
Assuntos
Adenocarcinoma/etiologia , Poeira , Prova Pericial/legislação & jurisprudência , Cavidade Nasal , Neoplasias Nasais/etiologia , Doenças Profissionais/etiologia , Exposição Ocupacional/efeitos adversos , Neoplasias dos Seios Paranasais/etiologia , Madeira/efeitos adversos , Adenocarcinoma/diagnóstico , Adenocarcinoma/radioterapia , Adenocarcinoma/cirurgia , Idoso , Terapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Cavidade Nasal/efeitos da radiação , Cavidade Nasal/cirurgia , Recidiva Local de Neoplasia/diagnóstico , Recidiva Local de Neoplasia/etiologia , Recidiva Local de Neoplasia/radioterapia , Recidiva Local de Neoplasia/cirurgia , Neoplasias Nasais/diagnóstico , Neoplasias Nasais/radioterapia , Neoplasias Nasais/cirurgia , Doenças Profissionais/diagnóstico , Doenças Profissionais/radioterapia , Doenças Profissionais/cirurgia , Exposição Ocupacional/legislação & jurisprudência , Neoplasias dos Seios Paranasais/diagnóstico , Neoplasias dos Seios Paranasais/radioterapia , Neoplasias dos Seios Paranasais/cirurgia , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/etiologia , Guias de Prática Clínica como Assunto , Lesões por Radiação/diagnóstico , Lesões por Radiação/etiologia , Radioterapia Adjuvante , Estudos Retrospectivos , Indenização aos Trabalhadores/legislação & jurisprudênciaRESUMO
OBJECTIVE: To assess the effects of repeated episodes of propofol-associated anesthesia on quality of recovery from anesthesia, clinical status, and erythrocyte physiology in cats. DESIGN: Original study. ANIMALS: 37 cats undergoing short-duration anesthesia for radiotherapy. PROCEDURES: Twice daily on 5 consecutive days, 13 cats with squamous cell carcinoma of the nasal planum (group 1) underwent anesthesia: first via administration of propofol or a midazolam (0.2 mg/kg [0.09 mg/lb])-propofol combination and then via administration of ketamine and midazolam each day (latter data were not analyzed). During a 19-day period, 24 cats with vaccine associated sarcoma (group 2) were anesthetized 12 times with propofol or a midazolam-propofol combination. Anesthesia was maintained with propofol in both groups. Hematologic analysis was performed before, during, and on completion of radiotherapy; changes in Hct and hemoglobin concentration between groups were compared. RESULTS: Mean duration of anesthesia was 8.1 minutes (range, 5 to 20 minutes); no adverse events were detected during recovery. Total dose of propofol administered did not differ between groups 1 (6.34 mg/kg [2.88 mg/lb]) and 2 (4.71 mg/kg [2.14 mg/lb]). Midazolam administration decreased the propofol dose by 26%. Overall decreases from baseline in Hct and hemoglobin concentration were not significantly different between the 2 groups, nor clinically important; however, compared with baseline, values in group 2 were significantly lower after 6 and 12 anesthetic episodes for both protocols. Heinz bodies were identified in low numbers in both groups during radiotherapy. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that repeated propofol-associated short-duration anesthesia does not lead to clinically relevant hematologic changes in cats undergoing short-duration radiotherapy.
Assuntos
Anestesia Intravenosa/veterinária , Anestésicos Intravenosos/administração & dosagem , Gatos/fisiologia , Hematócrito/veterinária , Hemoglobinas/análise , Propofol/administração & dosagem , Anestesia Intravenosa/efeitos adversos , Anestesia Intravenosa/métodos , Anestésicos Intravenosos/efeitos adversos , Animais , Pressão Sanguínea/efeitos dos fármacos , Carcinoma de Células Escamosas/radioterapia , Carcinoma de Células Escamosas/veterinária , Doenças do Gato/radioterapia , Gatos/sangue , Combinação de Medicamentos , Feminino , Corpos de Heinz , Ketamina/administração & dosagem , Masculino , Midazolam/administração & dosagem , Neoplasias Nasais/radioterapia , Neoplasias Nasais/veterinária , Propofol/efeitos adversos , Sarcoma/radioterapia , Sarcoma/veterinária , Resultado do Tratamento , Vacinação/efeitos adversos , Vacinação/veterináriaRESUMO
INTRODUCTION: This article reports on the effectiveness, cosmetic outcome, and costs of interstitial high-dose-rate (HDR) brachytherapy for early-stage cancer of the nasal vestibule (NV) proper and/or columella high-dose-rate (HDR). METHODS AND MATERIALS: Tumor control, survival, cosmetic outcome, functional results, and costs were established in 64 T1/T2N0 nasal vestibule cancers treated from 1991-2005 by fractionated interstitial radiation therapy (IRT) only. Total dose is 44 Gy: 2 fractions of 3 Gy per day, 6-hour interval, first and last fraction 4 Gy. Cosmesis is noted in the chart by the medical doctor during follow-up, by the patient (visual analog scale), and by a panel. Finally, full hospital costs are computed. RESULTS: A local relapse-free survival rate of 92% at 5 years was obtained. Four local failures were observed; all four patients were salvaged. The neck was not treated electively; no neck recurrence in follow-up was seen. Excellent cosmetic and functional results were observed. With 10 days admission for full treatment, hospital costs amounted to euro5772 (7044 US dollars). CONCLUSION: Excellent tumor control, cosmesis, and function of nasal airway passage can be achieved when HDR-IRT for T1/T2N0 NV cancers is used. For the more advanced cancers (Wang classification: T3 tumor stage), we elect to treat by local excision followed by a reconstructive procedure. The costs, admission to hospital inclusive, for treatment by HDR-IRT amounts to euro5772 (7044 US dollars). This contrasts substantially with the full hospital costs when NV cancers are treated by plastic reconstructive surgery, being on average threefold as expensive.
Assuntos
Braquiterapia/métodos , Carcinoma Basocelular/radioterapia , Carcinoma de Células Escamosas/radioterapia , Estética , Neoplasias Nasais/radioterapia , Braquiterapia/efeitos adversos , Braquiterapia/economia , Carcinoma Basocelular/economia , Carcinoma Basocelular/patologia , Carcinoma de Células Escamosas/economia , Carcinoma de Células Escamosas/patologia , Feminino , Custos de Cuidados de Saúde , Humanos , Masculino , Cavidade Nasal , Estadiamento de Neoplasias , Neoplasias Nasais/economia , Neoplasias Nasais/patologia , FotografaçãoRESUMO
En un grupo de 21 niños con sarcomas de partes blandas de localizaciones parameningeas (nasofaringe, senos perinasales, órbita, fosas nasales y oido medio) tratados con la asociación radioterapia-poliquimioterapia se alcanzó una supervivencia del 27,09% En 12 niños, donde la irradiación estuvo localizada en el área del tumor con una dosis en el rango de 56 a 60 Gy,la supervivencia alcanzada fue de 20.83%, estabilizada a partir de los 38 meses de evoluciòn. En 9 niños la irradiación incluyó, además del tumor primario con dosis entre 55 y 65 Guy, la irradiación de todo el cráneo con dosis entre 24 y 30 Guy, con una supervivencia del 40 %, estabilizada en el mes 13 de la evolución. En ambos grupos se empleó la quimioterapia con la combinación vincristina,ciclofosfamida y actinomicin D (VAC) y además la adriamicina (VACA). La diferencia en la supervivencia alcanzada en ambos grupos es estadisticamente significativa a favor de la irradiación extendida al cráneo y demuestra la utilidad de esta en el tratamiento de estos tumores parameníngeos